John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 19,000 shares at $30.27 ($574K) on 2015-09-08, disclosed to the SEC on 2015-09-10.
Scheduled sale ($574k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.16 | 4,799 | $140K | 24.4% |
| 2 | $30.27 | 9,028 | $273K | 47.6% |
| 3 | $31.06 | 5,173 | $161K | 28.0% |
| Total | $30.20 avg | 19,000 | $574K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-08-12 | $542K | — | Filing → |